健康160通过港交所聆讯,连续3年亏损,2024年末资产负债率130%

公司研究室
Sep 05

(原标题:健康160通过港交所聆讯,连续3年亏损,2024年末资产负债率130%)出品|公司研究室IPO组文|曲奇9月4日,健康160通过港交所聆讯。健康160,前身为“就医160”,是一家起源于2005年的数字医疗服务提供商。健康160的业务可以分为两大块:一是传统的医药健康用品批零业务,二是基于“健康160”平台的数字医疗健康解决方案业务。其中,医药健康用品业务是健康160当前最重要的收入来源...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10